One-Rod Contraceptive Implant as a Postpartum Contraceptive Option
Abstract
In an effort to increase family planning coverage, reduce high-risk pregnancies, reduce the incidence of unwanted pregnancies, and reduce maternal mortality, long-acting reversible contraceptives (LARC) in the form of IUDs and implants are routinely used as postpartum contraception. Postpartum contraception use supports the reduction of maternal and infant morbidity and mortality rates.The use of implant contraception has undergone several developments from six-rods, two-rods to one-rod.
A one-rod contraceptive refers to a type of LARC implant, typically containing a progestin hormone, that is inserted under the skin of a woman’s upper arm. Included among the contraceptive techniques thought safe for immediate postpartum usage, it offers efficient, reversible contraception for several years (generally 3-5 years depending on the brand). A postpartum contraceptive helps to avoid unplanned and closely spaced pregnancies, allows a woman’s body enough time to recover from birth, therefore lowering the risk of maternal anemia and other complications, also progestin-only contraceptives and non-hormonal strategies are usually preferred for breastfeeding women as estrogen-containing methods may lower milk production.
Full Text:
PDFReferences
Hofmeyr GJ, Ryan RJ, Mussa A, Bame B, Malima S, Moloi T, et al. Improving Postpregnancy Contraceptive Method Choice and PLoS One Long-Acting Reversible Contraception Provision in Botswana: A Quality Improvement Pilot. BMJ Sex Reprod Heal. 2023 Oct;49(4):293–7.
Jahanfar S, Maurer O, Lapidow A, Oberoi AR, Steinfeldt M, Ali M. A Meta-Analysis Into the Mediatory Effects of Family Planning Utilization on Complications of Pregnancy in Women of Reproductive Age. PLoS One. 2024;19(3):1–16. Available from: http://dx.doi.org/10.1371/journal.pone.0294475
Rocca ML, Palumbo AR, Visconti F, Di Carlo C. Safety and Benefits of Contraceptives Implants: A Systematic Review. Pharmaceuticals. 2021;14(6):1–26.
International Federation of Gynaecology and Obstetrics (FIGO). Technical Brief: Implementing Postpartum Intrauterine Device (PPIUD) Services in Healthcare Facilities. London: FIGO; 2020.
American College of Obstetricians and Gynecologists. Postpartum Birth Control: Frequently Asked Questions. ACOG. Washington, DC; 2023. Available from: https://www.acog.org/womens-health/faqs/postpartum-birth-control
Bibi Qureshi S, Shoukat A, Maroof P, Mushraf S. Postpartum Contraception Utilization and Its Impact on Inter Pregnancy Interval Among Mothers Accessing Maternity Services in The Public Sector Hospital of Hyderabad Sindh. Pakistan J Med Sci. 2019;35(6):1482–7.
Morroni C, Glasier A. Increasing the Use of Effective Postpartum Contraception: Urgent and Possible. Lancet Glob Heal. 2020;8(3):e316–7. Available from: http://dx.doi.org/10.1016/S2214-109X(20)30045-0
Grandi G, Del Savio MC, Tassi A, Facchinetti F. Postpartum Contraception: A Matter of Guidelines. Int J Gynecol Obstet. 2023;164(1):56–65.
Gunardi ER, Khusen D, Pasidri Y, Manan H, Dewantiningrum J, Hendarto H. A New Family Planning Single Rod Implant Has Been Born and Is Ready to Be Marketed. Teikyo Med J. 2021;44(5):5–7.
Barton BE, Erickson JA, Allred SI, Jeffries JM, Stephens KK, Hunter MI, et al. Reversible Female Contraceptives: Historical, Current, and Future Perspectives. Biol Reprod. 2024;110(1):14–32.
Han L, Creinin MD, Hemon A, Glasier A, Chen MJ, Edelman A. Mechanism of Action of A 0.075 mg Norgestrel Progestogen-Only Pill 2. Effect on Cervical Mucus and Theoretical Risk of Conception. Contraception. 2022;112:43–7. Available from: https://doi.org/10.1016/j.contraception.2022.03.016
Bhatia P, Nangia S, Aggarwal S, Tewari C. Implanon: Subdermal Single Rod Contraceptive Implant. J Obstet Gynecol India. 2011;61(4):422–5.
Ali M, Akin A, Bahamondes L, Brache V, Habib N, Landoulsi S, et al. Extended Use Up to 5 Years of The Etonogestrel-Releasing Subdermal Contraceptive Implant: Comparison to Levonorgestrel-Releasing Subdermal Implant. Hum Reprod. 2016;31(11):2491–8.
Averbach S, Kakaire O, McDiehl R, Dehlendorf C, Lester F, Steinauer J. The Effect of Immediate Postpartum Levonorgestrel Contraceptive Implant Use on Breastfeeding and Infant Growth: A Randomized Controlled Trial. Contraception. 2019;99(2):87–93.
Floyd JL, Beasley AD, Swaim LS, Turrentine MA, Nijjar JB. Association of Immediate Postpartum Etonogestrel Implant Insertion and Venous Thromboembolism. Obstet Gynecol. 2020;135(6). Available from: https://journals.lww.com/greenjournal/fulltext/2020/06000/association_of_immediate_postpartum_etonogestrel.7.aspx
Gunardi ER, Susilo SA. Menstrual Pattern and Characteristics of One-Rod and Two-Rod Levonorgestrel Implant Users. Obstet Gynecol Int. 2021;2021:1–7.
Santoso B, Susanto L, Tunjungseto A, Widjayanti Y, Fernandus ED, Devianti Putri B. The Effectiveness, Changes in Body Weight, and Menstrual Cycle Between 2 Rods and 1 Rod Contraceptive Implants after 12 Months of Insertion. Curr Women s Heal Rev. 2024;20(2):113–9.
DOI: http://dx.doi.org/10.24198/obgynia.v8i2.960
Refbacks
- There are currently no refbacks.

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
_CROSREF22.jpg)









